Circulating vaspin and its relationship with insulin sensitivity, adiponectin, and liver histology in subjects with non-alcoholic steatohepatitis

References

• Kotronen A, Yki-Järvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008;28:27–38.
   PubMed Web of Science ®Google Scholar
• Tsochatzis EA, Manolakopoulos S, Papatheodoridis GV, Archimandritis AJ. Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications. Scand J Gastroenterol 2009;44:6–14.
   PubMed Web of Science ®Google Scholar
• Torer N, Ozenirler S, Yucel A, Bukan N, Erdem O. Importance of cytokines, oxidative stress and expression of BCL-2 in the pathogenesis of non-alcoholic steatohepatitis. Scand J Gastroenterol 2007;42:1095–101.
   PubMed Web of Science ®Google Scholar
• Tsochatzis EA, Papatheodoridis GV, Archimandritis AJ. Adipokines in nonalcoholic steatohepatitis: from pathogenesis to implications in diagnosis and therapy. Mediators Inflamm 2009;2009:831670.
   PubMed Web of Science ®Google Scholar
• Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A, Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci 2005;26:10610–15.
   Google Scholar
• Klöting N, Berndt J, Kralisch S, Kovacs P, Fasshauer M, Schön MR, Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun 2006;339:430–6.
   PubMed Web of Science ®Google Scholar
• Youn BS, Klöting N, Kratzsch J, Park JW, Lee N, Song ES, Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2008;57:372–7.
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–19.
   PubMed Web of Science ®Google Scholar
• Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23:57–63.
   PubMed Web of Science ®Google Scholar
• Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313–21.
   PubMed Web of Science ®Google Scholar
• Kukla M, Zwirska-Korczala K, Hartleb M, Waluga M, Chwist A, Kajor M, Serum chemerin and vaspin in non-alcoholic fatty liver disease. Scand J Gastroenterol 2010;45:235–42.
   PubMed Web of Science ®Google Scholar
• Aktas B, Yilmaz Y, Eren F, Yonal O, Kurt R, Alahdab YO, Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease. Metabolism 2011;60:544–9.
   PubMed Web of Science ®Google Scholar
• Seeger J, Ziegelmeier M, Bachmann A, Lössner U, Kratzsch J, Blüher M, Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab 2008;93:247–51.
   PubMed Web of Science ®Google Scholar
• Giomisi A, Kourtis A, Toulis KA, Anastasilakis AD, Makedou KG, Mouzaki M, Serum vaspin levels in normal pregnancy in comparison with non-pregnant women. Eur J Endocrinol 2011;164:579–83.
   PubMed Web of Science ®Google Scholar
• El-Mesallamy HO, Kassem DH, El-Demerdash E, Amin AI. Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus. Metabolism 2011;60:63–70.
   PubMed Web of Science ®Google Scholar
• Gulcelik NE, Karakaya J, Gedik A, Usman A, Gurlek A. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications. Eur J Endocrinol 2009;160:65–70.
   PubMed Web of Science ®Google Scholar
• Kadoglou NP, Kapelouzou A, Tsanikidis H, Vitta I, Liapis CD, Sailer N. Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes. Exp Clin Endocrinol Diabetes 2011;119:63–8.
   PubMed Web of Science ®Google Scholar
• Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Gravina A, Mereu R, Differential effects of candesartan and olmesartan on adipose tissue activity biomarkers in type II diabetic hypertensive patients. Hypertens Res 2010;33:790–5.
   PubMed Web of Science ®Google Scholar
• Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Gravina A, Mereu R, Effects of combination of sibutramine and l-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients. Metabolism 2011;60:421–9.
   PubMed Web of Science ®Google Scholar
• Dogru T, Karadurmus N, Tapan S, Genc H. Comment and reply on: Chemerin and vaspin in non-alcoholic fatty liver disease. Scand J Gastroenterol 2010;45:1000–1.
   PubMed Web of Science ®Google Scholar
• Guerre-Millo M. Adiponectin: an update. Diabetes Metab 2008;34:12–18.
   PubMed Web of Science ®Google Scholar
• Tilg H, Hotamisligil GS. Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance. Gastroenterology 2006;131:934–45.
   PubMed Web of Science ®Google Scholar
• Lanthier N, Leclercq IA. Adiponectin in non-alcoholic steatohepatitis: an ideal culprit, but what are the proofs of its guilt? J Gastroenterol Hepatol 2009;24:1584–6.
   PubMed Web of Science ®Google Scholar
• Ma H, Gomez V, Lu L, Yang X, Wu X, Xiao SY. Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2009;24:233–7.
   PubMed Web of Science ®Google Scholar
• Suleymanoglu S, Tascilar E, Pirgon O, Tapan S, Meral C, Abaci A. Vaspin and its correlation with insulin sensitivity indices in obese children. Diabetes Res Clin Pract 2009;3:325–8.
   Google Scholar
• Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002;51:2734–41.
   PubMed Web of Science ®Google Scholar